Cytoplasmic free calcium mobilization in platelets, expression of P-selectin, phosphatidylserine, and microparticle formation, measured by whole blood flow cytometry, in hypertensive patients. Effect of doxazosin GITS

Thrombosis Research

Volumn 117, Issue 4, 2006, Pages 403-409

  Labiós, Manuel ^a   Martínez, Marcial ^b   Gabriel, Francisco ^a   Guiral, Victoria ^a   Ruiz Aja, Sandra ^b   Aznar, Justo ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Doxazosin GITS; Flow cytometry; Free calcium mobilization; Hypertension; Platelet activation

Indexed keywords

DOXAZOSIN; PADGEM PROTEIN; PHOSPHATIDYLSERINE;

ADULT; AGED; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HYPERTENSION; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE MEMBRANE;

ANTIHYPERTENSIVE AGENTS; BLOOD PLATELETS; CALCIUM; CELL-DERIVED MICROPARTICLES; CYTOPLASM; DOXAZOSIN; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; P-SELECTIN; PHOSPHATIDYLSERINES;

EID: 32044437357     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.03.012     Document Type: Article

References (32)

1. W.P. Castelli, and K. Anderson A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study Am J Med 80 1986 23 32
2. R. Hernandez Hernandez, A. Carvajal, J. Guerrero Pajuelo, M. Armas de Hernandez, M. Armas Padilla, and O. Barragan The effect of doxazosin on platelet aggregation in normotensive subjects and patients with hypertension: an in vitro study Am Heart J 121 1991 389 394
3. G. Andrioli, R. Ortolani, L. Fontana, S. Gaino, P. Bellavite, and C. Lechi Study of platelet adhesion in patients with uncomplicated hypertension J Hypertens 14 1996 1215 1221
4. J. Valles, M.T. Santos, J. Aznar, M. Martinez, A. Moscardo, and M. Pinon Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo Blood 99 2002 3978 3984
5. J. Valles, M.T. Santos, A.J. Marcus, L.B. Safier, M.J. Broekman, and N. Islam Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins J Clin Invest 92 1993 1357 1365
6. E.M. Bevers, P. Comfurius, J.L. van Rijn, H.C. Hemker, and R.F. Zwaal Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets Eur J Biochem 122 1982 429 436
7. P.A. Holme, F. Brosstad, and N.O. Solum Platelet-derived microvesicles and activated platelets express factor Xa activity Blood Coagul Fibrinolysis 6 1995 302 310
8. S.O. Sage, J.E. Merritt, T.J. Hallam, and T.J. Rink Receptor-mediated calcium entry in fura-2-loaded human platelets stimulated with ADP and thrombin. Dual-wavelengths studies with Mn2+ Biochem J 258 1989 923 926
9. J.A. Ware, P.C. Johnson, M. Smith, and E.W. Salzman Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin J Clin Invest 77 1986 878 886
10. K.W. Tan, and S.A. Frise Efficacy and tolerability of doxazosin versus enalapril in the treatment of patients with mild-to-moderate hypertension Clin Ther 19 1997 459 470
11. L.N. Daae, and L. Westlie A 5-year comparison of doxazosin and atenolol in patients with mild-to-moderate hypertension: effects on blood pressure, serum lipids, and coronary heart disease risk Blood Press 7 1998 39 45
12. M. Chung, V. Vashi, J. Puente, M. Sweeney, and P. Meredith Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation Br J Clin Pharmacol 48 1999 678 687
13. N.A. Alarayyed, B.R. Graham, B.N. Prichard, and C.C. Smith The potentiation of adrenaline-induced in vitro platelet aggregation by ADP, collagen and serotonin and its inhibition by naftopidil and doxazosin in normal human subjects Br J Clin Pharmacol 39 1995 369 374
14. N.A. Alarayyed, M.B. Cooper, B.N. Prichard, D.J. Betteridge, and C.C. Smith In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine Br J Clin Pharmacol 43 1997 415 420
15. M. Labios, M. Martinez, F. Gabriel, S. Gomez-Biedma, V. Guiral, and M. Vivo Flow cytometric analysis of platelet activation in hypertensive patients. Effect of doxazosin Thromb Res 110 2003 203 208
16. M. do Ceu Monteiro, F. Sansonetty, M.J. Goncalves, and J.E. O'Connor Flow cytometric kinetic assay of calcium mobilization in whole blood platelets using Fluo-3 and CD41 Cytometry 35 1999 302 310
17. I. Os, and H.P. Stokke Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension. Doxazosin Investigators' Study Group J Cardiovasc Pharmacol 33 1999 791 797
18. S.A. Hamburger, and R.P. McEver GMP-140 mediates adhesion of stimulated platelets to neutrophils Blood 75 1990 550 554
19. T. Palabrica, R. Lobb, B.C. Furie, M. Aronovitz, C. Benjamin, and Y.M. Hsu Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets Nature 359 1992 848 851
20. H. Koyama, T. Maeno, S. Fukumoto, T. Shoji, T. Yamane, and H. Yokoyama Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans Circulation 108 2003 524 529
21. R.A. Preston, W. Jy, J.J. Jimenez, L.M. Mauro, L.L. Horstman, and M. Valle Effects of severe hypertension on endothelial and platelet microparticles Hypertension 41 2003 211 217
22. J. Dachary-Prigent, J.M. Pasquet, J.M. Freyssinet, and A.T. Nurden Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors Biochemistry 34 1995 11625 11634
23. R.F. Zwaal, and A.J. Schroit Pathophysiologic implications of membrane phospholipid asymmetry in blood cells Blood 89 1997 1121 1132
24. H. Haller, C. Lindschau, P. Quass, and A. Distler Protein phosphorylation and intracellular free calcium in platelets of patients with essential hypertension Am J Hypertens 5 1992 117 124
25. G. Caimi, R.L. Presti, C. Carollo, M. Musso, F. Porretto, and B. Canino Polymorphonuclear integrins, membrane fluidity, and cytosolic Ca(2+) content after activation in essential hypertension Hypertension 36 2000 813 817
26. A. Camilletti, N. Moretti, G. Giacchetti, E. Faloia, D. Martarelli, and F. Mantero Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients Am J Hypertens 14 2001 382 386
27. S. Gulati, M. Khullar, B.K. Sharma, and N.K. Ganguly Platelet calcium pump activity in essential hypertensives and their first-degree relatives Mol Cell Biochem 156 1996 37 42
28. J. Enouf, R. Bobe, C. Lacabaratz-Porret, R. Bredoux, E. Corvazier, and T. Kovacs The platelet Ca2+ transport ATPase system Platelets 8 1997 5 13
29. M.C. Michel, O.E. Brodde, and P.A. Insel Peripheral adrenergic receptors in hypertension Hypertension 16 1990 107 120
30. F. Portaluppi, R. Manfredini, K. Varani, S. Gessi, A. Caiazza, and P.A. Borea Platelet alpha2-adrenoceptor alterations in patients with essential hypertension are normalized after treatment with doxazosin but not propranolol J Hypertens 18 2000 217 221
31. J.A. Grant, and M.C. Scrutton Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation Nature 277 1979 659 661
32. T.J. Rink, and S.O. Sage Calcium signaling in human platelets Annu Rev Physiol 52 1990 431 449